<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Community-Based Medicine</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5033A559-126A-4C8C-9798-8FDCC4C74ACD"><gtr:id>5033A559-126A-4C8C-9798-8FDCC4C74ACD</gtr:id><gtr:firstName>Nicky</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Welton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802413"><gtr:id>042C7A22-77D2-4297-8A19-36AAF420BBAB</gtr:id><gtr:title>Expected Value of Information and Synthesis Methods for Research Prioritisation and Study Design</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802413</gtr:grantReference><gtr:abstractText>At present there is a gap between the way decisions are made about whether to adopt new treatments for use in the NHS, and the way decisions are made about whether more research is needed on these treatments. As a result, resources may be wasted researching treatments that were never likely to be cost-effective, or by adopting treatments which, if more evidence were collected, would not be cost-effective. It is possible to calculate the probability that a decision to adopt a treatment on the basis of current evidence would turn out to be the wrong decision if more evidence was collected, and how much resource waste and loss of quality of life this is likely to represent. These calculations provide an objective and fair method for informing the decision of which studies to fund, and how best to design those studies. The methods are, however, complex. This project aims to find ways of making the calculations easier so that they can be used more widely to help research funding bodies commission research that will help make better treatment decisions for patients in the NHS.</gtr:abstractText><gtr:technicalSummary>The National Institute for Health and Clinical Excellence (NICE) and similar bodies worldwide use formal modelling techniques to answer policy questions about whether to adopt a new technology for routine use. But a series of further policy issues then arise that are relevant to research commissioning bodies such as the National Institute for Health Research (NIHR) Health Technology Assessment Programme (NCCHTA) and the MRC: (a) is more evidence required to support the adoption of this technology (b) which model inputs in particular should we collect evidence on? (c) what research designs deliver the best societal pay-off from research? (d) what is the optimal sequence of multiple new studies? These questions can be addressed using Expected Value of Information (EVI) methods. 

While the principles of EVI methods are well understood, applications in health and medicine face technical challenges before they can be routinely implemented. These include: correlated model inputs; non-linear decision models; complex relationships between evidence and model inputs; heterogeneity in baseline characteristics, subgroups, and model uncertainty; biomarkers and biased evidence; optimisation over large design-spaces and optimal sequences of research. Changes in the policy environment, leading to coverage with evidence and risk-sharing schemes raise further technical challenges.

The aim of this proposal is to develop methods that address these technical challenges for EVI computation that are practical within the time constraints faced by NICE, NIHR NCCHTA, and those designing trials, and sensitive to the developing policy context. To achieve this, a series of carefully chosen worked illustrations will be assembled, covering the most important and commonly encountered evidence structures and cost-effectiveness models. The examples will include the design of randomised controlled trials, epidemiological studies, drug-development studies, use of biomarkers, and design of research portfolios. 

EVI analysis depends on the validity of underlying systematic review, evidence synthesis, and cost-effectiveness analysis, and has implications for all of these disciplines. The training element is designed to broaden my knowledge of these disciplines, and will expose me to policy considerations at National level surrounding the use of these methods in Health Technology Assessment. Thus ensuring the policy-relevance of the research, and facilitating future research across the whole EVI agenda.

Research findings will be disseminated through publications and presentations at international conferences. Wherever possible generic methods to prioritise and design new trials/studies will be made available for use in standard software. The worked exemplars and methods will form the basis of short courses and a book. 
400 words</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-04</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>393232</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Value of Information Methods Group</gtr:description><gtr:id>F2553CF4-55F0-43D1-908A-BB614306014F</gtr:id><gtr:impact>Welton NJ, Baio G, Strong M, Heath A. The role of value of information in trial design: are we missing an opportunity? Workshop. 3rd International Clinical Trials Methodology Conference, Glasgow 16th-17th November 2015

Short course on Statistical Methods for the Value of Information Analysis. 8-10 June 2016, University College London</gtr:impact><gtr:outcomeId>56d2d68cdb8214.88448461-1</gtr:outcomeId><gtr:partnerContribution>Developed materials for workshop. Organised and developed materials for short course.</gtr:partnerContribution><gtr:piContribution>Arranged and funded meetings. Developed materials for workshop. Organised and developed materials for short course.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Value of Information Methods Group</gtr:description><gtr:id>EB2D4D99-F513-4AD4-B8A4-D30276FA9FB1</gtr:id><gtr:impact>Welton NJ, Baio G, Strong M, Heath A. The role of value of information in trial design: are we missing an opportunity? Workshop. 3rd International Clinical Trials Methodology Conference, Glasgow 16th-17th November 2015

Short course on Statistical Methods for the Value of Information Analysis. 8-10 June 2016, University College London</gtr:impact><gtr:outcomeId>56d2d68cdb8214.88448461-2</gtr:outcomeId><gtr:partnerContribution>Developed materials for workshop. Organised and developed materials for short course.</gtr:partnerContribution><gtr:piContribution>Arranged and funded meetings. Developed materials for workshop. Organised and developed materials for short course.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Model Based Network Meta-Analysis</gtr:description><gtr:id>BAD52EAF-6DA7-4A24-8598-40717BBE843D</gtr:id><gtr:impact>MRC MICA grant</gtr:impact><gtr:outcomeId>545bf5a57f2896.15896134-1</gtr:outcomeId><gtr:partnerContribution>Pfizer bring model based meta-analysis expertise and and access to datasets and relevant examples.</gtr:partnerContribution><gtr:piContribution>Successful MRC grant, that is just about to begin. Pfizer bring model based meta-analysis expertise, and Bristol bring network meta-analysis skills. Funds come jointly from MRC MICA Methodology Research grant and from pfizer.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Laura Flight Fellowship</gtr:description><gtr:id>FF22134D-18D6-4947-BDA0-AFB218609601</gtr:id><gtr:impact>Non yet</gtr:impact><gtr:outcomeId>56d2d7ebe76f60.82205987-1</gtr:outcomeId><gtr:partnerContribution>Supervision</gtr:partnerContribution><gtr:piContribution>Advisory</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Covariates in NMA</gtr:description><gtr:id>E9F639E6-2F45-4C27-98EC-F48258BD9308</gtr:id><gtr:impact>Publications in preparation.</gtr:impact><gtr:outcomeId>545f7705482835.52576517-1</gtr:outcomeId><gtr:partnerContribution>fellowship, publications, datasets</gtr:partnerContribution><gtr:piContribution>Provide expertise on network meta-analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tracey Sachs fellowship</gtr:description><gtr:id>54E3FFE0-54D7-482D-A833-59C18BD3D9FE</gtr:id><gtr:impact>Only just started - no outputs yet.</gtr:impact><gtr:outcomeId>545f77abc12c89.04342150-1</gtr:outcomeId><gtr:partnerContribution>Tracey Sach fellowship: papers, research</gtr:partnerContribution><gtr:piContribution>Provide advice on expected value of information computation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Becky Boucher fellowship</gtr:description><gtr:id>B5DFFE65-3792-49F0-8FB2-E3EB5B5FC36A</gtr:id><gtr:impact>None yet - just started</gtr:impact><gtr:outcomeId>545f783e45ee44.24037513-1</gtr:outcomeId><gtr:partnerContribution>Fellowship programme of work, publications.</gtr:partnerContribution><gtr:piContribution>Provide advice on statistical methodology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Ashma Krishan PhD</gtr:description><gtr:id>F7BAB09B-9E41-450D-B225-425EF082F4FF</gtr:id><gtr:impact>Non yet</gtr:impact><gtr:outcomeId>56d2d71ed918d6.72303753-1</gtr:outcomeId><gtr:partnerContribution>Supervision</gtr:partnerContribution><gtr:piContribution>Supervision</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation at NICE Away Day 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DCF04FF7-5268-439F-AE39-6432116BA5BB</gtr:id><gtr:impact>Made NICE Committee members and Evidence Review Groups aware of the potential for the use of external information to better inform the shape of survival curves, to help make better reimbursement decisions.

The survival curve reconstruction methods have been used in submissions to NICE technology appraisals. The committee members have an improved understanding of the key issues in extrapolating beyond trial follow-up periods.</gtr:impact><gtr:outcomeId>545f7e41c1c442.24705622</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISPOR Workshop The role of value of information in HTA: are we missing an opportunity?</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ECEA5B4C-EEEA-4C6B-9460-1A682160297C</gtr:id><gtr:impact>Workshop delivered at ISPOR conference attended by policy makers, industry and academics. The workshop led to a lively debate, and requests for information.</gtr:impact><gtr:outcomeId>58bdc54910a448.95092073</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Indirect &amp; Mixed Treatment Comparisons. All Wales Medicines Strategy Group Training</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>47DCDFD8-A4A3-4CB1-8067-EEF345D7B9AF</gtr:id><gtr:impact>Gave invited presentation on network meta-analysis to the All Wales Medicines Strategy Group Training Day to provide training in their methods of technology appraisals</gtr:impact><gtr:outcomeId>56d2e0796abe51.68864505</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Evidence Synthesis MasterClass</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CBA4EB44-E87E-46E9-A91C-3115896685CE</gtr:id><gtr:impact>Gave session and practical &amp;quot;What makes a good submission to NICE? Evidence synthesis.&amp;quot; NICE/Decision Support Unit/ ABPI (Association of the British Pharmaceutical Industry) Masterclass.</gtr:impact><gtr:outcomeId>56d2dfebeb0511.55765362</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Value of information and its potential role in guidelines. NICE-NCC Technical Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5BC08B40-7648-4A67-9305-C65A0B57D28D</gtr:id><gtr:impact>Gave invited presentation on the role of value of information in guidelines to NICE National Coordinating Centre Technical staff.</gtr:impact><gtr:outcomeId>56d2e17a0c1b50.90099529</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>201060</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MICA: Model Based Network Meta-Analysis for Pharmacometrics and Drug-Development.</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>46FCDF2A-5EF6-4A8B-B5EE-F447119DC59C</gtr:id><gtr:outcomeId>545f75360e85a1.68333596</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13820</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>programme grant RP-PG-0609-10171 Negative pressure wound dressings</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>3119B545-3001-4E4A-8BE0-6E337A827D36</gtr:id><gtr:outcomeId>nZBH4TwQE9M0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>145106</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC research grant G1001338 synthesis of time to event data</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9315C221-3DC4-4474-A524-E1C340D0A765</gtr:id><gtr:outcomeId>T8Q592Ud6fa0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>What interventions improve outcomes for children exposed to domestic abuse: a systematic review, evidence synthesis, and research recommendations.</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>340C4C2A-3C07-47CA-B979-F8B1C2600C72</gtr:id><gtr:outcomeId>sqYLRhWcfdH</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>230304</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research for Patient Benefit</gtr:department><gtr:description>The choice between hip prosthetic bearing surfaces in total hip replacement: evidence synthesis, statistical analysis and decision modelling to evaluate the effectiveness and cost-effectiveness of prosthetic implants for the NHS.</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>PB-PG-0613-31032</gtr:fundingRef><gtr:id>5C60091A-C306-409A-B9A1-EF224D98BCEB</gtr:id><gtr:outcomeId>545f73ff8cad79.39633248</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26618</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship: Sarah Donegan</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8AE6A28B-E711-463D-A3A8-5E32BAF375E4</gtr:id><gtr:outcomeId>545f722b75fd40.09988655</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>173500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC research grant Chlamydia G0801947</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A59764C8-3B18-48CB-9916-B2E4F3DCFF0B</gtr:id><gtr:outcomeId>hYXRRcCbbF50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>327489</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NICE Clinical Guidelines Technical Support Unit</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health and Care Excellence (NICE)</gtr:fundingOrg><gtr:id>B2592C8B-99EC-443F-B378-0A11CF3B7577</gtr:id><gtr:outcomeId>56d2da048aa000.75001036</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>162371</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Which method is best for the induction of labour: A systematic review, network meta-analysis and cost effectiveness analysis.</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>FD16012B-49F2-4A41-B973-4A24B1A88404</gtr:id><gtr:outcomeId>DkWZkD3s3fd</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>313872</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NICE Clinical Guidelines Technical Support Unit</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>National Institute for Health and Care Excellence (NICE)</gtr:fundingOrg><gtr:id>65F766EA-6749-46B1-B975-16E8D5A62C10</gtr:id><gtr:outcomeId>NZXz1aV7Atf0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>181379</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Screening Strategies for Atrial Fibrillation: A Systematic Review and Cost-Effectiveness Analysis.</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C38EA2BE-C299-4D42-A1BB-3D5A55B54F15</gtr:id><gtr:outcomeId>545f76295be760.63019494</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1999968</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>What are the indications for prescribing antidepressants that will lead to a clinical benefit? NIHR programme grant.</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>B428EBBB-7DF3-4ED8-A510-55D6B8ACAEE7</gtr:id><gtr:outcomeId>BfeBrz9zPMD0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8566</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Hubs for Trial Methodology Network</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>639CAF8E-4B23-4529-BE60-F6F3E959187B</gtr:id><gtr:outcomeId>g1X8q47DP3H0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300355</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>Effectiveness and cost-effectiveness of new anticoagulants for venous thromboembolism and sroke prevention in atrial fibrillation.</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C72A6E98-25D0-45EE-8AD8-BFB32E80CCAD</gtr:id><gtr:outcomeId>puPm6e3f2Mk</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9160</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Network of Hubs for Trials Methodology Research (HTMR)</gtr:department><gtr:description>Meta-Modelling for Value of Information Calculations Workshop.</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6D2E986B-AF86-4026-9929-A91C0542780D</gtr:id><gtr:outcomeId>545f7493b7aec4.37670532</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2233801</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Programme Grant for Applied Research</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>RP-PG-0514-20012</gtr:fundingRef><gtr:id>6E18CC08-DFAB-479D-ACD8-57AEF748D6CA</gtr:id><gtr:outcomeId>56d2daee934bd0.03118233</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126799</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>08/70/01 value of information for IVIG research grant</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F2AEC4BF-6661-44ED-A43F-277FAF923045</gtr:id><gtr:outcomeId>PZAbn7UViFN0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>232052</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant mapping outcomes G0901488</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6990A30D-B4C5-43C9-850D-401CB8545BA4</gtr:id><gtr:outcomeId>nYmyx646rSs0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>335124</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>The effectiveness, acceptability and cost-effectiveness of psychosocial interventions for maltreated children and adolescents: An evidence synthesis.</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>BD480604-9AF5-4D1F-B8DA-30F881AD4FDB</gtr:id><gtr:outcomeId>D5jeZpLMcWR</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3865761</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Health Protection Unit: Evaluation of Interventions</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>HPRU-2012-10026</gtr:fundingRef><gtr:id>34424007-BE3E-4DB4-9E3E-D5A74B882A39</gtr:id><gtr:outcomeId>545f732090c8f9.93333895</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>329881</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>10/98 Whole body physiotherapy package for hypermobility call</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>541264F8-589A-4C86-822D-84A9FEC46FD8</gtr:id><gtr:outcomeId>RiXK82PAzuj0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1990000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC ConDuCT-II Hub for Trial Methodology Research</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A9AB43DC-2C98-487C-8A18-7E082ACDBF2A</gtr:id><gtr:outcomeId>545f72b301c5d4.05930399</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>91015</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>08/60/01 Electronic aides to smoking cessation research grant</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D529D24D-FB3D-42FF-B37D-BF50EA2529C9</gtr:id><gtr:outcomeId>or3P5rytX9k0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>274851</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of a method for adjusting trial results for biases in meta-analysis: combining generic evidence on bias with detailed trial assessment.</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>98CF10BF-6E12-4E33-BF93-435530103DFA</gtr:id><gtr:outcomeId>MZZJkCBP59v</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7532</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Hub for Trials Methodology Research Network (biologics)</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B82130D5-81AC-4664-98DC-2796C942FE16</gtr:id><gtr:outcomeId>EotQhrJiwNX0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE Evidence Synthesis TSDs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4F1F00A9-206C-4A46-ACE0-BCC60B3B8AC8</gtr:id><gtr:impact>Guidance on methodology for decisions made by NICE Technology Appraisals Committees. These Technical Support Documents are recommended in the NICE Methods Guide, and are cited widely in submissions to NICE.</gtr:impact><gtr:outcomeId>HDHgnnyrj8C</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.nicedsu.org.uk/evidence-synthesis-tsd-series(2391675).htm</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Urinary Incontinence Clinical Guideline</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>40ADC34F-8AA8-4ABA-BD5B-B92D6794BA9F</gtr:id><gtr:outcomeId>pa1ik2hrRf9</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE Techology Appraisal committee member</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FB28D641-5C68-4DF9-A677-ED1DEA2C1ED6</gtr:id><gtr:impact>The guidance issued from the NICE Technology Appraisals committee are mandatory within 3 months, and therefore have direct impact. The guidance is based on an assessment of cost-effectiveness, and so improves efficiency of health care</gtr:impact><gtr:outcomeId>cCL4BRRFbRn</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short Course on Bias Adjustment in Meta-Analysis and Network Meta-Analysis</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3F284602-9E6B-4FDE-B98B-218E7140CA1F</gtr:id><gtr:impact>Training course tailored to the needs of technical teams on NICE clinical guidelines.</gtr:impact><gtr:outcomeId>58bdcd74af8fc3.46057190</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Schizophrenia Clinical Guideline</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EDCE9D01-48AE-4528-9BAC-C38A0798D8B0</gtr:id><gtr:outcomeId>mokBM1e3XPP</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Masterclass for NICE Decision Support Unit/ABPI on What makes a good submission to NICE?</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44BFB042-5C4A-4094-82D8-0C9D5E032EB1</gtr:id><gtr:impact>The training helps pharmaceutical companies prepare good submissions to NICE to enable NICE to better appraise their health technologies. This means that clearer reimbursement decisions can be made, benefiting patients and healthcare providers.</gtr:impact><gtr:outcomeId>58bdcc2f873524.20122135</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advanced Breast Caner Guideline</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FADEB6C3-6FE2-42AE-8558-880CEE4D69E5</gtr:id><gtr:outcomeId>C64F1ULZZds</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>InterTASC workshop presentation</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3473CD5A-16EB-4996-A17E-3EA22E5C64A6</gtr:id><gtr:outcomeId>545f7b0ce51ba9.79449511</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short Course on Statistical Methods for Value of Information Analysis</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>717A5FF6-5E5F-4DA8-BD67-E99A7EEFB0DB</gtr:id><gtr:outcomeId>58bdcadf0fc406.90887625</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short course Inconsistency in network meta-analysis</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>DD38EA6B-ADB7-406F-B7BF-88532BD78523</gtr:id><gtr:impact>Training was given in-house to ICON plc who are consultants tot he pharmaceutical industry, helping them prepare submissions to NICE.</gtr:impact><gtr:outcomeId>58bdccd57d6f92.66217020</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short courses in Mixed Treatment Comparisons</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>18F4CBB1-92E3-437F-89ED-0ACE456F3CBE</gtr:id><gtr:impact>Run many courses on indirect and mixed treatment comparison methods in the UK, abroad, and for industry. The methods are now widely used in submissions to NICE, and in the development of NICE Clinical Guidelines</gtr:impact><gtr:outcomeId>LC9rHT3hpV8</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Short course on Meta-Analysis of Diagnostic Test Accuracy Studies</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA56F2CC-EC93-43AD-8EC9-E556DA03E5D6</gtr:id><gtr:outcomeId>EhXmkPtEMQp</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0C617A6F-EF28-4BDB-A6DA-D3E5567CC9F9</gtr:id><gtr:title>Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>56d2ca6171be55.76354910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1D38D11-30D8-45D8-B10B-5D4964369C03</gtr:id><gtr:title>Evidence Synthesis for Decision Making in Healthcare - Welton/Evidence Synthesis for Decision Making in Healthcare</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ae2fe192b41cb5e3c10df466797986"><gtr:id>72ae2fe192b41cb5e3c10df466797986</gtr:id><gtr:otherNames>Welton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>9780470061091</gtr:isbn><gtr:outcomeId>dB3dKWM9WPS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF42552E-D337-404C-AE39-ED6F0DCB9EE9</gtr:id><gtr:title>Strategies for efficient computation of the expected value of partial perfect information.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_540e166e16667e4fc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EA531AA-4E7B-4966-9F82-C3227F8046C7</gtr:id><gtr:title>Approaches for synthesising complex mental health interventions in meta-analysis.</gtr:title><gtr:parentPublicationTitle>Evidence-based mental health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1362-0347</gtr:issn><gtr:outcomeId>56d2ca61494fd2.06031935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52ACFC88-1271-4D4A-9810-3FCF51082A7A</gtr:id><gtr:title>Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Critical care (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/410b2df32adbc9d15ed167f05d421fba"><gtr:id>410b2df32adbc9d15ed167f05d421fba</gtr:id><gtr:otherNames>Soares MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1364-8535</gtr:issn><gtr:outcomeId>56d2ca64c0e185.88991922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9C5D3E9-42E9-4449-902B-2FB24CED4D02</gtr:id><gtr:title>Models for potentially biased evidence in meta-analysis using empirically based priors</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ae2fe192b41cb5e3c10df466797986"><gtr:id>72ae2fe192b41cb5e3c10df466797986</gtr:id><gtr:otherNames>Welton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>D92602A685C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08B1F5B0-A699-4D8C-AC32-E71AA99121D1</gtr:id><gtr:title>Modeling the need for hip and knee replacement surgery. Part 1. A two-stage cross-cohort approach.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>F318FD85361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52FC0BFF-826C-4DBE-9841-2E103C656714</gtr:id><gtr:title>Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>545bf2a9bec915.08568058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AA972C6-EEB2-4205-B05F-4D9D19983A16</gtr:id><gtr:title>Choosing the best first line oral drug agent in patients with pulmonary hypertension: evidence from a network meta-analysis.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbe3476cd4be1c60248817d5f751d28c"><gtr:id>cbe3476cd4be1c60248817d5f751d28c</gtr:id><gtr:otherNames>Biondi-Zoccai G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn><gtr:outcomeId>pm_15268_28_23755974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C079371-BAE3-46DF-8A3E-C6F77B21EAB7</gtr:id><gtr:title>Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56d2ca64673745.52389180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8104A184-D198-421E-B3ED-532BAA2B9280</gtr:id><gtr:title>Linear inference for mixed treatment comparison meta-analysis: a two-stage approach.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>56d2ca65203239.26246241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A11B4390-CE5F-4504-A504-D77E1122051F</gtr:id><gtr:title>Expected value of sample information for multi-arm cluster randomized trials with binary outcomes.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_24085289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A01DC413-F149-42C2-9924-45E620DD2988</gtr:id><gtr:title>Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e1966ce9dde19752aa6dfac19d28cbc"><gtr:id>3e1966ce9dde19752aa6dfac19d28cbc</gtr:id><gtr:otherNames>Guyot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>pm_15268_28_22297116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EEE68C6-F0DE-41C8-9D8C-47F5AB43DFD2</gtr:id><gtr:title>Accounting for correlation in network meta-analysis with multi-arm trials.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65153cfa4dff679356b35f691ad0a8d8"><gtr:id>65153cfa4dff679356b35f691ad0a8d8</gtr:id><gtr:otherNames>Franchini AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>DqzaBjBZnMt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ECF2031-E726-4065-A8FE-879C4DBA0A8B</gtr:id><gtr:title>Effects of study precision and risk of bias in networks of interventions: a network meta-epidemiological study.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ebc4f11dec9d4d57b57e112a64716ee"><gtr:id>7ebc4f11dec9d4d57b57e112a64716ee</gtr:id><gtr:otherNames>Chaimani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>pm_15268_28_23811232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8A78793-EDBC-4D4C-8E56-4731F61F8182</gtr:id><gtr:title>Evidence synthesis for decision making 1: introduction.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23804506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43BDBDC8-476F-4CF7-824D-F57D3754D901</gtr:id><gtr:title>A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.</gtr:title><gtr:parentPublicationTitle>Nicotine &amp; tobacco research : official journal of the Society for Research on Nicotine and Tobacco</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-2203</gtr:issn><gtr:outcomeId>FCB93D7874E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13F8F44A-565B-4B2A-9BFB-DD6BF62B9531</gtr:id><gtr:title>Network meta-analysis with competing risk outcomes.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>YECsqhmb24p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9ACC556-5E61-47C1-9C6A-9CC5F18057F4</gtr:id><gtr:title>Study designs to detect sponsorship and other biases in systematic reviews.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>kqw43gVGZvq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85542058-B648-41CE-A95B-6202609647B5</gtr:id><gtr:title>Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23804510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EE9C39A-6E16-4711-B0D9-A962834BB4D6</gtr:id><gtr:title>Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow-up times reported inconsistently: a smoking cessation case-study</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>doi_15268_rssa_12018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC354127-FFD9-47AE-A0CB-05F844CA4B59</gtr:id><gtr:title>Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>QsDj1CrWHJ7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B59D9C4D-FF16-49E0-AB3B-C1BB2FCCF9BC</gtr:id><gtr:title>Evidence synthesis for decision making 5: the baseline natural history model.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23804509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE8DCE57-3282-4D0C-8D17-634FAFA753B9</gtr:id><gtr:title>Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>pm_15268_28_23813703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E1F4F1D-A649-4CBC-A27D-9C6CF76F9AB4</gtr:id><gtr:title>Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: placing back-calculations in a formal statistical framework.</gtr:title><gtr:parentPublicationTitle>The Science of the total environment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93ea4f380bdda00b56e830cfa03018a1"><gtr:id>93ea4f380bdda00b56e830cfa03018a1</gtr:id><gtr:otherNames>Jones HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0048-9697</gtr:issn><gtr:outcomeId>545bf2a9e6d252.85972986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C93B1ACE-376A-4231-82F6-84C6A6C46AE6</gtr:id><gtr:title>Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.</gtr:title><gtr:parentPublicationTitle>Current medical research and opinion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53af5e4feadeaafd7a9676fee4cad351"><gtr:id>53af5e4feadeaafd7a9676fee4cad351</gtr:id><gtr:otherNames>Edwards SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-7995</gtr:issn><gtr:outcomeId>8EA4AE14739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5249B583-0230-4F45-8F94-B5A6D5F7DEAE</gtr:id><gtr:title>Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23804508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CE0F58F-1AD4-4CE5-AAD3-5FDED78789C6</gtr:id><gtr:title>How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>iT7KPXn2866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F952BFE3-9268-41D3-9E38-3BBF9864FA42</gtr:id><gtr:title>A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e19fd8a8121d4f7e205c7947bd96c101"><gtr:id>e19fd8a8121d4f7e205c7947bd96c101</gtr:id><gtr:otherNames>Salaminios G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a89a0af985393.69323484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA4D5531-214B-4AE2-922C-37A2F5132931</gtr:id><gtr:title>Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6a21002105f03f66eed67137e868864"><gtr:id>b6a21002105f03f66eed67137e868864</gtr:id><gtr:otherNames>Hickman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>pm_15268_28_23600694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8324438C-DF59-4BE9-9897-7095F7557866</gtr:id><gtr:title>Indirect and mixed treatment comparisons in arthritis research.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>UHeav1n6cmv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F63195-46EA-46BF-8096-06A242EAA060</gtr:id><gtr:title>Novel presentational approaches were developed for reporting network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c21de76c7e3cadfe24af44fe490ed82"><gtr:id>8c21de76c7e3cadfe24af44fe490ed82</gtr:id><gtr:otherNames>Tan SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>545bf3b4d9e684.91777620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06A3755E-4A4B-49A9-82A6-07828F343FF0</gtr:id><gtr:title>Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e1966ce9dde19752aa6dfac19d28cbc"><gtr:id>3e1966ce9dde19752aa6dfac19d28cbc</gtr:id><gtr:otherNames>Guyot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>niZ38YTUfw4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D588C8E-E446-4159-9BB4-5A6769C973BE</gtr:id><gtr:title>How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bddbcebab2c35ddc738c63f1da257313"><gtr:id>bddbcebab2c35ddc738c63f1da257313</gtr:id><gtr:otherNames>Thomas KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5aa951fe4f5837.53997179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9262BA42-3B44-4C7F-B8B5-70A83AA11981</gtr:id><gtr:title>Tocolytic therapy for preterm delivery: systematic review and network meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e488196600ddac40fa539eaba3c37ea"><gtr:id>9e488196600ddac40fa539eaba3c37ea</gtr:id><gtr:otherNames>Haas DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_15268_28_23048010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BC92111-E0BA-45A7-8E19-49E082770BBE</gtr:id><gtr:title>Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2acfc41eb448432e43cc7988de271120"><gtr:id>2acfc41eb448432e43cc7988de271120</gtr:id><gtr:otherNames>Saramago Goncalves P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>56d2ca61d27522.99230173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9327A2C9-AA6B-4042-87EE-0A462798D5CA</gtr:id><gtr:title>Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b0df5909d25e9aeadb7e428e8fbeca8"><gtr:id>1b0df5909d25e9aeadb7e428e8fbeca8</gtr:id><gtr:otherNames>Burch J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>A18D234FF96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2487BD20-7DDA-4B77-81CF-4D2EF8FDCDAB</gtr:id><gtr:title>Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d486cc7eda5ce0e045910ffcc2e54d4"><gtr:id>4d486cc7eda5ce0e045910ffcc2e54d4</gtr:id><gtr:otherNames>Colbourn TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>9B3FF75ACA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>001C5E08-687D-4772-84AF-67237A7158DF</gtr:id><gtr:title>Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bd522716636d6c40c2c616ae992e297"><gtr:id>9bd522716636d6c40c2c616ae992e297</gtr:id><gtr:otherNames>White IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>B7CD0656FE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>856C7CB5-7358-44D2-91B5-777E0491C870</gtr:id><gtr:title>Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>9A41FAA7FF7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19B24BDB-7E68-4952-A29C-1D435D12194A</gtr:id><gtr:title>Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43f1871207fb7f431f2cb0284c410db"><gtr:id>a43f1871207fb7f431f2cb0284c410db</gtr:id><gtr:otherNames>van Valkenhoef G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>56d2ca634c4504.53466436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E12B27C3-BB63-476E-8A4B-CC601A5AB0EE</gtr:id><gtr:title>Geographical variation in the provision of elective primary hip and knee replacement: the role of socio-demographic, hospital and distance variables.</gtr:title><gtr:parentPublicationTitle>Journal of public health (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1741-3842</gtr:issn><gtr:outcomeId>A6C2525E74A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>395E5913-C0AF-4EF0-924E-F904BFE4B11B</gtr:id><gtr:title>Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/745e53f4056b8e3888d31d91becbb6f4"><gtr:id>745e53f4056b8e3888d31d91becbb6f4</gtr:id><gtr:otherNames>Chen YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_15268_28_23046909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F233E89F-2A91-4DD1-BB14-D321E66FE94A</gtr:id><gtr:title>The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e6647a5451d9500a92f0ae53f00f9b1"><gtr:id>6e6647a5451d9500a92f0ae53f00f9b1</gtr:id><gtr:otherNames>Van den Bruel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>KAbSPUDEtUm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F02FC48-77EC-4FF2-A7A0-2FFDDEA494C5</gtr:id><gtr:title>Diagnostic value of symptoms of oesophagogastric cancers in primary care: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The British journal of general practice : the journal of the Royal College of General Practitioners</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58c0256d75251b61f70d6183ff06e2f8"><gtr:id>58c0256d75251b61f70d6183ff06e2f8</gtr:id><gtr:otherNames>Astin MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-1643</gtr:issn><gtr:outcomeId>56d2d30ae77275.39122052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E2BB910-B57C-4D30-A2EC-90C8D27B3C40</gtr:id><gtr:title>Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_15268_28_22989478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BB079ED-EE38-4AD7-AF01-D4D2956FD8ED</gtr:id><gtr:title>Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>545bf2aa181037.96229165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CDF7332-FA2F-4D72-AB37-B2E5045DE38E</gtr:id><gtr:title>Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>pm_15268_28_22945832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8404A64-278E-4E93-95C5-D18082CEE7ED</gtr:id><gtr:title>Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23804507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68F927A3-E614-403A-83FF-8231E7F690B9</gtr:id><gtr:title>An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/410b2df32adbc9d15ed167f05d421fba"><gtr:id>410b2df32adbc9d15ed167f05d421fba</gtr:id><gtr:otherNames>Soares MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_15268_28_22361003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C673B2C-5132-4C69-98DB-093C3BD5479B</gtr:id><gtr:title>Incidence of Chlamydia trachomatis infection in women in England: two methods of estimation.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>pm_15268_28_23759367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D35BAE0D-C697-4E28-B0E2-F3CA33604077</gtr:id><gtr:title>BAYESIAN ECONOMETRIC MODELLING OF OBSERVATIONAL DATA FOR COST-EFFECTIVENESS ANALYSIS</gtr:title><gtr:parentPublicationTitle>VALUE IN HEALTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/288b28cdc5481adc5da4b18f18490644"><gtr:id>288b28cdc5481adc5da4b18f18490644</gtr:id><gtr:otherNames>Goncalves Saramago P.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>5a3606328fd859.25199608</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071CC2B8-2E81-4387-96CA-9E088ED59572</gtr:id><gtr:title>Treatment comparisons for decision making: facing the problems of sparse and few data</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9c25d1f8a590c53bc5fb75092f4bd46"><gtr:id>e9c25d1f8a590c53bc5fb75092f4bd46</gtr:id><gtr:otherNames>Soares M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>doi_15268_rssa_12010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5181678-D90E-48E5-BB36-6F8F493D2793</gtr:id><gtr:title>Exploring the research decision space: the expected value of information for sequential research designs.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c3a2f228fb294dc6ddd16042fb4b2fb"><gtr:id>6c3a2f228fb294dc6ddd16042fb4b2fb</gtr:id><gtr:otherNames>Griffin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>G3G1hmmaVrb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEC099EB-4019-4519-AD18-9C75A9842E64</gtr:id><gtr:title>Research decisions in the face of heterogeneity: what can a new study tell us?</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ae2fe192b41cb5e3c10df466797986"><gtr:id>72ae2fe192b41cb5e3c10df466797986</gtr:id><gtr:otherNames>Welton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>LhweYbjhyC3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3C261C0-CE44-4AF1-A9A5-0408E5AF6AD6</gtr:id><gtr:title>A selection model for accounting for publication bias in a full network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88257f2601d17b612282489f0b70afdf"><gtr:id>88257f2601d17b612282489f0b70afdf</gtr:id><gtr:otherNames>Mavridis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>545bf3b5178620.59431459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9428E96-2239-4CFC-85BF-F958986A6F63</gtr:id><gtr:title>Parameterization of treatment effects for meta-analysis in multi-state Markov models.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>Ptn3uaxS4WT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5E870A2-3768-481A-A1FF-B87FCB832A3C</gtr:id><gtr:title>Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.</gtr:title><gtr:parentPublicationTitle>Open medicine : a peer-reviewed, independent, open-access journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1231ad946bfee424cc7256c3b1594e"><gtr:id>6f1231ad946bfee424cc7256c3b1594e</gtr:id><gtr:otherNames>McIntosh B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>s8tYp8WuQZK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BE0522E-E0A5-4FAD-85BA-E24FC17231C4</gtr:id><gtr:title>Modeling the need for hip and knee replacement surgery. Part 2. Incorporating census data to provide small-area predictions for need with uncertainty bounds.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>657733838CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26BF8E80-213E-4B93-90FA-51CC1EF8C611</gtr:id><gtr:title>A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33e9ddcbe905dd1d7c412a987c50eced"><gtr:id>33e9ddcbe905dd1d7c412a987c50eced</gtr:id><gtr:otherNames>Turner NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>56d2ca6494aab4.42090061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3307B620-4D59-4528-8494-A5949A026994</gtr:id><gtr:title>A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccb690a8433b877932358cc3cfb5ea98"><gtr:id>ccb690a8433b877932358cc3cfb5ea98</gtr:id><gtr:otherNames>Bluebelle Study Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a89a282e7f2c1.17340597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF9F6ABA-6770-4E84-A390-A902169E0AF2</gtr:id><gtr:title>Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.</gtr:title><gtr:parentPublicationTitle>The European journal of health economics : HEPAC : health economics in prevention and care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aff61449d3f08fe613f9f6c9d0e46261"><gtr:id>aff61449d3f08fe613f9f6c9d0e46261</gtr:id><gtr:otherNames>Mantopoulos T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1618-7598</gtr:issn><gtr:outcomeId>56d2ca638def90.28934735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F989055-F48B-4536-917E-E7150CEE71E6</gtr:id><gtr:title>Correction: interpretation of random effects meta-analysis in decision models.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>315C4F59275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1D90CBD-67C2-4FF7-A996-22392F086D5B</gtr:id><gtr:title>Differences in relative and absolute effectiveness of oral P2Yinhibition in men and women: a meta-analysis and modelling study.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9b0f4918d947592726bd93a400eaa2b"><gtr:id>c9b0f4918d947592726bd93a400eaa2b</gtr:id><gtr:otherNames>Lee KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>5a89a1b50826b8.65233381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB2555EB-D2FC-4F3F-A997-63CCB04BEE01</gtr:id><gtr:title>Labour induction with prostaglandins: a systematic review and network meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c82414dabe811d35aba7a3fc3b81b83a"><gtr:id>c82414dabe811d35aba7a3fc3b81b83a</gtr:id><gtr:otherNames>Alfirevic Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56d2c726d85564.16874945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36630198-40F1-44ED-878A-487AE367C67B</gtr:id><gtr:title>Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus.</gtr:title><gtr:parentPublicationTitle>The American journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c8a96850cd5f5d6159653b5c6759e02"><gtr:id>2c8a96850cd5f5d6159653b5c6759e02</gtr:id><gtr:otherNames>Navarese EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9149</gtr:issn><gtr:outcomeId>pm_15268_28_23352266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D900C55-EF76-49D4-8CFF-93BA5E376682</gtr:id><gtr:title>Costs and cost-effectiveness of spinal cord stimulation (SCS) for failed back surgery syndrome: an observational study in a workers' compensation population.</gtr:title><gtr:parentPublicationTitle>Spine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/982fc5363b94ff9a1c1c8d8352ef89c4"><gtr:id>982fc5363b94ff9a1c1c8d8352ef89c4</gtr:id><gtr:otherNames>Hollingworth W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0362-2436</gtr:issn><gtr:outcomeId>enV6bGdsrRu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D37E0595-09F8-4469-97A7-B7FEFA5C4266</gtr:id><gtr:title>Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d36f40355dfa4d0b2709e1c0fc5bfc"><gtr:id>c4d36f40355dfa4d0b2709e1c0fc5bfc</gtr:id><gtr:otherNames>Thom H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>5a89a2c09fd3f3.27817052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43650ED0-B8B2-4893-BBC8-4EBD6E9687B6</gtr:id><gtr:title>Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5B51446CA0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C2A74E5-7CA8-465E-ABBB-F4D7F00A0B84</gtr:id><gtr:title>Evaluating novel agent effects in multiple-treatments meta-regression.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f85fadd4328b3023227ef6758795cbb"><gtr:id>7f85fadd4328b3023227ef6758795cbb</gtr:id><gtr:otherNames>Salanti G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>qd1XtniCFgn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA07DE5C-889A-482D-90D8-F798B3648B57</gtr:id><gtr:title>An overview of models used in economic analyses of biologic therapies for arthritis--from current diversity to future consensus.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>FrNhqvLWU4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61199605-0DD6-4AC2-A163-CCA6BEBE5D47</gtr:id><gtr:title>Evidence synthesis for decision making 7: a reviewer's checklist.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23804511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ED8A4A7-7E4E-4032-8DD8-4991183AB7A4</gtr:id><gtr:title>Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>atRZBTn6iX1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CDB1719-631B-42E2-BF18-CA0AD2DBB4B3</gtr:id><gtr:title>Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open-angle glaucoma and ocular hypertension.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8683f8eb382285cea66ec9b5cfc09a26"><gtr:id>8683f8eb382285cea66ec9b5cfc09a26</gtr:id><gtr:otherNames>Dakin HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>hgWQ573SWQD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BFC9D1B-7663-49A6-9E1F-F83AA9C1BDE0</gtr:id><gtr:title>Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d3c79501cc960b5fbffe2c07639e40"><gtr:id>a6d3c79501cc960b5fbffe2c07639e40</gtr:id><gtr:otherNames>Govan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>JNMFJmCWDaH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DE1B37F-D13F-4004-8888-E317792FA117</gtr:id><gtr:title>Minimal clinically important difference on the Beck Depression Inventory--II according to the patient's perspective.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d36da206f23e4c493f35af41192fc13"><gtr:id>5d36da206f23e4c493f35af41192fc13</gtr:id><gtr:otherNames>Button KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>56d2ca62dec1c6.02219525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C3ED4D-34A2-4903-A432-D74A3C3DC0B3</gtr:id><gtr:title>Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>q39xZun22hP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73F52054-D2FB-4B89-B1B8-062A9ADB2E39</gtr:id><gtr:title>Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54b7eb1d56bf4de52564acb44c9cb766"><gtr:id>54b7eb1d56bf4de52564acb44c9cb766</gtr:id><gtr:otherNames>Wandel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>DkdpTv1s4uE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77636E1E-4D1D-4F5B-8E28-5808417AEE22</gtr:id><gtr:title>Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>pm_15268_28_22949217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA88D64F-7A4C-44F5-8937-FE15EA58AAE2</gtr:id><gtr:title>A Bayesian approach to analysing the cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d99186fe36784093a89ae67dc4a70fcb"><gtr:id>d99186fe36784093a89ae67dc4a70fcb</gtr:id><gtr:otherNames>Brown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>F01094E8D09</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71DD56B2-28ED-4E9A-AA32-190123766495</gtr:id><gtr:title>Selecting the best scale for measuring treatment effect in a network meta-analysis: a case study in childhood nocturnal enuresis.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>i7WuhYNARtZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A502D64-A17C-4349-80B8-97278476D132</gtr:id><gtr:title>Bayesian methods for evidence synthesis in cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>PharmacoEconomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1170-7690</gtr:issn><gtr:outcomeId>1C2234134EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DCEC690-BB09-4D18-B70F-836740C393C6</gtr:id><gtr:title>Research prioritization based on expected value of partial perfect information: a case-study on interventions to increase uptake of breast cancer screening</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ae2fe192b41cb5e3c10df466797986"><gtr:id>72ae2fe192b41cb5e3c10df466797986</gtr:id><gtr:otherNames>Welton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>D9D356476B5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E59A0395-EC48-499D-9F49-118A082A1310</gtr:id><gtr:title>? Markov model for longitudinal studies with incomplete dichotomous outcomes.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e64b0e3c4d089e5c8463eee502cfd327"><gtr:id>e64b0e3c4d089e5c8463eee502cfd327</gtr:id><gtr:otherNames>Efthimiou O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1539-1604</gtr:issn><gtr:outcomeId>58bd71390ec4b6.18297695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B364747-5D21-4B9D-BE2C-923F3F692CD9</gtr:id><gtr:title>Value of Information: We've Got Speed, What More Do We Need?</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56d2ca64108ad8.35781837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D428CF1A-EAFE-4F83-B9C5-24CA362843D7</gtr:id><gtr:title>Network meta-analysis: a norm for comparative effectiveness?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62f63221dc061f0b790a217a27e32074"><gtr:id>62f63221dc061f0b790a217a27e32074</gtr:id><gtr:otherNames>Higgins JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56d2ca631d4fc1.50879393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C19051C1-CB7D-42E3-83E2-EE6F3C4BE846</gtr:id><gtr:title>Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>Q1AroG4wBsa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BEBE23E-80F7-4A53-B6CB-2B9B4F6CBC64</gtr:id><gtr:title>The Effectiveness of Targeted Interventions for Children Exposed to Domestic Violence: Measuring Success in Ways that Matter to Children, Parents and Professionals</gtr:title><gtr:parentPublicationTitle>Child Abuse Review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b609f310760a51ffd38c33d0831374ea"><gtr:id>b609f310760a51ffd38c33d0831374ea</gtr:id><gtr:otherNames>Howarth E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d2d30b478366.05680353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E12AECEC-79D7-467E-A650-CBE5DC72F1C5</gtr:id><gtr:title>Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: a review of recent practice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5fd3df21484b6f6203c5ef10c4edc32"><gtr:id>a5fd3df21484b6f6203c5ef10c4edc32</gtr:id><gtr:otherNames>Donegan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d2d30b1b9157.33863670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39C9909E-6406-4DEC-B2C3-5A3F4EC31138</gtr:id><gtr:title>Extending Treatment Networks in Health Technology Assessment: How Far Should We Go?</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd5f5a88b189727f08440f53ef02f97"><gtr:id>6dd5f5a88b189727f08440f53ef02f97</gtr:id><gtr:otherNames>Caldwell DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>56d2ca63b6ba51.29865451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69414EE0-7517-44AD-B9F9-2F83E4DC1F05</gtr:id><gtr:title>Linear inference for mixed treatment comparison meta-analysis: A two-stage approach.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708ada18da20f695ad331397095f2bf0"><gtr:id>708ada18da20f695ad331397095f2bf0</gtr:id><gtr:otherNames>Lu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>autBXtRA8Nh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D5C491-FF8F-4522-9A1C-330642EA5521</gtr:id><gtr:title>Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b0669e9e1ad7202d315f3b53701b838"><gtr:id>1b0669e9e1ad7202d315f3b53701b838</gtr:id><gtr:otherNames>Leal J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1877-7821</gtr:issn><gtr:outcomeId>5a89a06f56fa98.49337311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57AF8CFE-4478-4ACB-BD46-8FC8934B6009</gtr:id><gtr:title>Automating network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43f1871207fb7f431f2cb0284c410db"><gtr:id>a43f1871207fb7f431f2cb0284c410db</gtr:id><gtr:otherNames>van Valkenhoef G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>56d2ca64eb9d75.56214604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF4D1535-3703-4107-91EB-3F5D93CCE0E0</gtr:id><gtr:title>Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pgxERVAUVPv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E9C5BE1-35FC-45F6-A2CC-58B09009F69B</gtr:id><gtr:title>Multiparameter evidence synthesis in epidemiology and medical decision-making.</gtr:title><gtr:parentPublicationTitle>Journal of health services research &amp; policy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be634fac835e6c6b3a8ab2f90cde0628"><gtr:id>be634fac835e6c6b3a8ab2f90cde0628</gtr:id><gtr:otherNames>Ades AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1355-8196</gtr:issn><gtr:outcomeId>69ED671CAF9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E81BD77-9202-4EC6-B6B0-32CD877B7867</gtr:id><gtr:title>Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02be8b3f27b6d4932f6308c697cbd43"><gtr:id>d02be8b3f27b6d4932f6308c697cbd43</gtr:id><gtr:otherNames>Welton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>2496BB69C19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2668746D-2B7D-4D3D-9738-857EEB21C4CF</gtr:id><gtr:title>Checking consistency in mixed treatment comparison meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>eeh6p4FhkxZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D25AC2E9-593E-4C24-BF81-7EC48945F7AD</gtr:id><gtr:title>The choice between hip prosthetic bearing surfaces in total hip replacement: a protocol for a systematic review and network meta-analysis.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d3eac8c78cee02eae916476dd18e55"><gtr:id>c6d3eac8c78cee02eae916476dd18e55</gtr:id><gtr:otherNames>Marques EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>56d2ca619d8786.80425920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23BF664A-0C5A-499C-B8C4-519569054DDC</gtr:id><gtr:title>Inequalities in rates of renal replacement therapy in England: does it matter who you are or where you live?</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>WGWnz1D5u87</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48BC2080-1D3F-4B69-8986-AECD832AD57C</gtr:id><gtr:title>Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5a8847acc685cbc20c964dce9ac52e"><gtr:id>9d5a8847acc685cbc20c964dce9ac52e</gtr:id><gtr:otherNames>Dias S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_15268_28_23104435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A646BC8C-73FC-454E-894E-8050C00DD45B</gtr:id><gtr:title>How much tubal factor infertility is caused by Chlamydia? Estimates based on serological evidence corrected for sensitivity and specificity.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>pm_15268_28_22801343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39B07B7B-B213-4D23-836E-6D4AA41C895B</gtr:id><gtr:title>Equity in access to total joint replacement of the hip and knee in England: cross sectional study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/766538433b036c5ae9f0f6974c0ce0c3"><gtr:id>766538433b036c5ae9f0f6974c0ce0c3</gtr:id><gtr:otherNames>Judge A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>b5kiMBsvrdV</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802413</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>